XHKG
1508
Market cap6.18bUSD
Jul 09, Last price
1.14HKD
1D
-2.56%
1Q
-16.79%
Jan 2017
-38.04%
IPO
-58.24%
Name
China Reinsurance Group Corp
Chart & Performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
China Reinsurance (Group) Corporation, along with its affiliated companies, functions as a leading reinsurance enterprise operating within the People's Republic of China and internationally. Its diverse business activities are structured into key segments, including Property and Casualty Reinsurance, Life and Health Reinsurance, Primary Property and Casualty Insurance, Asset Management, and other ancillary divisions. The company delivers a wide array of reinsurance solutions covering risks such as motor vehicles, commercial and household property, engineering, marine hull and cargo, liability, credit and guarantee, personal accident, health, agriculture, life and annuity, space and aviation, energy, and nuclear risks. Beyond reinsurance, it also offers comprehensive insurance agency services, which involve risk identification, assessment, and consultation; insurance program design and procurement; policy and claims administration; disaster and accident prevention management; holistic risk management; and the arrangement of reinsurance. Furthermore, its service portfolio extends to asset management, insurance brokerage, risk evaluation and oversight, underwriting agency services, risk advisory, management consulting, and investment management. The corporation is also active in issuing bonds. Its engagement also encompasses an e-commerce business and the provision of various multi-asset investment products, such as project-based financing programs, asset-backed securities, and investment initiatives for infrastructure and real estate. Established in 1949, China Reinsurance (Group) Corporation's principal office is located in Beijing, People's Republic of China, and it operates as a subsidiary of Central Huijin Investment Ltd.
Valuation
Title CNY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||